Ishampu "Etriveks": imiyalelo, izalathiso

Ukhwekhwe ye entlonzeni sisifo non-ezosulelayo. Pathology akuthethi engozini ubomi babantu, kodwa Awonakalise nzulu imbonakalo umntu. Kungenxa yoko le nto isifo iba umthombo ezahlukeneyo nezakhiwo. Ukhwekhwe luphawulwa umlinganiswa elide yomhla nezolo. Ngexesha i exacerbation isigulane lifumana sokudlathuka kweenwele kakhulu entloko kukho amabala enamaxolo ebomvu. Ishampu "Etriveks" lidla Kucetyiswa ukuba unyango lwe ukhwekhwe. esebenzisa isicelo lokufundisa ivumela ukuyifunda.

inkcazelo emfutshane

Ishampu "Etriveks" sikhokelo kubekwe corticosteroids (glucocorticosteroid) yenzelwe ukusetyenziswa yangaphandle.

It has iziphumo eziliqela yinzuzo kwi eziphilayo:

• anti-ukudumba,
• antiexudativ,
• antiproliferative,
• antiallergic,
• antipruritic.

Ngeshampu Kucetyiswa ukuba unyango izigulane abanengxaki ukhwekhwe ye entlonzeni.

Eziphembelela ngezifo ndlela usebenzisa iziphumo ezifana:

• kunciphisa i exudation arhabaxa;
• kunciphisa ukwenziwa lymphokines;
• kuthintela olwenzeka yomda neutrophils;
• abangaphangeliyo intshukumo macrophage;
• kunciphisa inkqubo nokungena;
• kunciphisa umfutho granulation.

Umenzi ishampu - France, elabhoratri "Galderma".

Ukudalwa kwendlela

Eyona nto iphambili ukulungiselela clobetasol propionate. Eli candelo libonelela isiphumo eyimfuneko konwaywa ishampu emzimbeni womntu.

Ngokutsho umyalelo kuthetha iquka la macandelo alandelayo:

• propionate clobetasol;
• betaine coco;
• Ethanol (96%);
• sodium lauryl sulfate ;
• sodium citrate;
• polyquaternium;
• monohydrate acid citric;
• amanzi okuhlamba.

Ubungqina obubonakalayo buxela

Ishampu ubekelwe ku:

• ukhwekhwe ye entlonzeni;
• planus ulele;
• onokhwekhwe;
• zomzimba lupus discoid ;
• Izifo yesikhumba abaxhathisayo kwezinye corticosteroids.

Iindlela inikwa ukunqanda likakade sifo kunye nokunika unyango yesondlo. iziyobisi Applied ekulweni ukhwekhwe kwizigulane abadala. Esi sixhobo ayisetyenziselwa unyango kwabantwana. Ishampu "Etriveks" umyalelo akukhuthazwa ukuba unyango lwezigulane ogama ubudala ongaphantsi kweminyaka eli-18.

umthamo

Ngoku jonga indlela yokusebenzisa ishampu ukuba ukhwekhwe le entlonzeni. Ikhondo ephambili unyango lubandakanya ukusetyenziswa yonke imihla esi sixhobo. Kulo mzekelo, isicelo ishampu kuphela iinwele kwindawo entloko.

unyango olusebenzayo ulandele ezi zincomo:

1. Faka ishampu yonke imihla "Etriveks" kwezi ndawo zichaphazelekayo entloko. Umphezulu webala kufuneka isikhumba owomileyo. Ngocoselelo Hlikihla ishampu kungena dermis. Kuba unyango olunye bonke ubuso entloko ngokwaneleyo 0,5 zobugcisa. l. ithetha. Oku malunga 7.5 ml. Musa ukulibala ukuba uhlambe izandla zakho kakuhle.
2. Ngoku ukushiya ishampu ukuba ukhwekhwe phezu kwentloko ngu imizuzu 15 Kule meko umphezulu iinwele kufuneka Ukuqukumbela. Emva kweli xesha, ahlambe iinwele zakho kakuhle ngaphantsi namanzi ahambayo.
3. Ngoko kuyacetyiswa ukuba kusetyenziswe ishampu eqhelekileyo. Ndihlambe iinwele zenu. Emva koko, uzomisa ngendlela eqhelekileyo.

Ubude unyango - de ukuphiliswa ngokupheleleyo. Noko ke, umlinganiselo ayikwazi ngaphezulu kweeveki ngaphezulu kwe-4. Ukuba emva kweli thuba anithanga nibone impucuko kwimpilo, kufuneka kuqhubeka ukusebenzisa ishampu. Kufuneka isicelo kugqirha ofanelekileyo moshilongo ngakumbi.

Ukongeza, cinga la macebiso equlethe ukulungiselela abstract:

1. Ukuba usebenzisa i ishampu ukuba ukhwekhwe phezu kwentloko nje unyango yesondlo, kucetyiswa ukuba ahlambe iinwele zakho "Etriveks" kuthetha kabini ngeveki.
2. Emva kweveki 4-ikhosi yabaqalayo, isigulane liya kuhlala inani elincinane izikali psoriatic. Ngoko abantu kufuneka ukusebenzisa ishampu amaxesha-2 ngeveki ukuphelisa ngokupheleleyo isiphumo esibi kunye ukuze bazikhusele ingozi ukuphinda. Ezo prophylaxis kufuneka kuqhube iinyanga ezintandathu.
3. Ukuba kuyimfuneko, ukuba izifundo phindwa unyango, kuthetha ukusetyenziswa ishampu mihla le ikhutshwa phandle. Noko ke, impatho enjalo kunokwenzeka kuphela emva kokubonisana ugqirha phantsi kweliso lakhe.

Izimo

Kufuneka ukuzama amisele ishampu. Musa ukulibala ukuba, njengaye nawuphi na amayeza, iye ezinye Izimo. Ngoko ke, ngaphambi kokubhenela namayeza, qiniseka ukuba ukuhlola, oko kunokubangela umonakalo omkhulu phantsi naziphi na ezimbi.

Ngoko ke, lo ishampu into contraindicated kubantu abanengxaki:

• amagciwane, izilonda iintsholongwane okanye viral ulusu (herpes simplex, varicella, isikhumba isifo sephepha, actinomycosis);
• induna vulgaris;
• Skin Oncology;
• Rosacea;
• dermatitis perioral;
• Gaida node scrapie;
• perianal kunye ukurhawuzelela zangasese;
• ufunga ilweyile;
• obubonakala cutaneous of negcushuwa;
• pustular eqhelekileyo, uqweqwe ukhwekhwe.

Ukongeza, le isixhobo masingaze sisetyenziselwe:

• abantwana;
• abasetyhini abakhulelweyo;
• abantu banda uvakalelo isithako esebenzayo (Clobetasol);
• mame.

imiphumela emibi

Ngeshampu abe ngumthombo basabele ngendlela embi. Ngoko ke, ukuba unguye njengokhetho lokuqala ukunyanga esi sixhobo, kodwa ubukele kwimpilo-ntle yakho. Xa side effects esirhesha ukunganyamezelani namayeza, qiniseka ukuba ayeke unyango.

Ngoko ke zintoni kwinkcaso ze isigulane kunokubangela ishampu "Etriveks"? Guide ibonisa abasabela ilandelayo:

1. Skin. Ngokufuthi abantu alatha lubandakanywe nezenzo amaqhakuva, folliculitis. Kakhulu ngaphantsi rhoqo, izigulane ezikhala urticaria, isikhumba yoma, telangiectasias. Okunye ukubuyekeza lubonisa ukulunywa kabi ukuluma yasekuhlaleni.
2. Amaziko mbono. Amaninzi ngexesha impatho yabantu senze into yokuba kukho imvakalelo elivuthayo ngamandla emehlweni.

Ixabiso le-ishampu

ngempumelelo Yimalini oku zonga kubathengi? Ngelishwa, akukho sezandleni leziyobisi cheap ishampu "Etriveks". Ixabiso kuthetha (60 ml igutyana) kwi-avareji uyahluka 837-930 engange.

Ukuba oyifunayo, Kakade ke, uyakwazi ukufumana noogxa. Noko ke, emva kokufunda angqina ezininzi nomonde, omnye singatsho kakuhle ukuba ichiza "Etriveks" into ethandwa kakhulu kuba inika unyango obalaseleyo. Ngokutsho kubaxumi yanelisekile, ngokuphumelelayo ishenxisa ingxaki kwaye uthintele ukuphinda. Yiloo nto abantu abaninzi bakhetha ukuya ishampu "Etriveks".